Neo7Bioscience, Inc.
John Catanzaro is the CEO and Co-founder of Neo7Bioscience, Inc., a company focused on creating individualized therapeutics through advanced molecular analysis, leveraging 25 years of clinical experience. Catanzaro has a diverse background, having co-founded several companies including HealthCoach7 and GeneSavvy, and served as Chief Product Developer for SpacePharma, where efforts concentrated on drug development in microgravity. Previous roles include CEO and Founder of Health and Wellness Institute and HWIFC Cancer Treatment, specializing in precision immunotherapy and personalized cancer therapies. Catanzaro's academic credentials include a Doctor of Naturopathic Medicine from Bastyr University, a PhD in Theology from Bethany Divinity Seminary, and ongoing studies in Genetics and Genomics at Stanford University. Additionally, experience in coaching baseball showcases a commitment to mentorship and team development.
This person is not in any teams
Neo7Bioscience, Inc.
Neo7Bioscience, Inc. is an industry leader in the creation of precise molecular designs for neurological disease, cancer, autoimmune, and chronic illnesses. Neo7Bioscience works with other organizations and develops new technologies for astrobiological science and systems biology for applications in deep space and orbit in the fields of genomics, proteomics, peptide engineering, bacteriophage research, and molecular medicine.